Poseida Therapeutics Inc Revenue per Employee (PSTX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Poseida Therapeutics Inc   (NASDAQ: PSTX)
 

Poseida Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 667.19% in the third quarter 2024, year on year to cumulative value of $151 million, Poseida Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 457,145. The productivity of Poseida Therapeutics Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 154 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1335, from total ranking in previous quarter at 2216. Poseida Therapeutics Inc has 330 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PSTX Revenue per Employee (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Revenue Change 667.19 % 29.78 % 172.09 % 148.68 % -91.96 %
Sales per Employee (TTM) $ 457,145 268,067 250,006 196,070 150,785
PSTX's Total Ranking # 1335 # 2216 # 0 # 0 # 2747
Seq. Revenue Change 176.24 % -7.71 % 12.59 % 167.27 % -53.27 %

PSTX Company Profile >> Back to PSTX Efficiency Comparisons >> Compare PSTX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 16
Healthcare Sector # 155
Overall Market # 1335

Revenue per Employee Statistics
High Average Low
$ 483,070 $ 345,242 $ 158,967
(Jun 30 2023)   (Sep 30 2023)



Financial Statements
Poseida Therapeutics Inc 's Revenue MRQ $ 72 Millions Visit PSTX's Income Statement
Poseida Therapeutics Inc 's Revenues TTM $ 151 Millions Visit PSTX's aggregate revenue growth
What are PSTX's Sales? Visit PSTX's Sales by Segment




Other Ratios
Poseida Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PSTX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PSTX's Competitors
Revenue per Employee for PSTX's Suppliers
Revenue per Employee for PSTX's Customers

You may also want to know
PSTX's Sales Growth Rates PSTX's Pe Price to earnings ratio PSTX's Receivables Turnover Ratio PSTX's Stock Quote
PSTX's Net Income Growth Rates PSTX's Ps Price to Sales ratio PSTX's Sales per Employee PSTX's Asset Turnover Ratio
PSTX's Net Margin PSTX's Pb Price to Book ratio PSTX's Financial Strength Ratios PSTX's Dividend Payout Ratio
Date modified: 2026-09-18T13:11:05+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2024Number of Employees Sep 30 2024
Biolife Solutions Inc   795,858.06 $ 123.358  Million 155 
Veru Inc   790,678.10 $ 15.814  Million 20 
Eton Pharmaceuticals Inc   763,795.45 $ 33.607  Million 44 
Blueprint Medicines Corporation  756,414.09 $ 440.233  Million 582 
Xtant Medical Holdings Inc   747,827.81 $ 112.922  Million 151 
Arcellx Inc   745,540.67 $ 155.818  Million 209 
Evolus Inc   743,491.02 $ 248.326  Million 334 
Ati Physical Therapy Inc   741,863.00 $ 741.863  Million 1,000 
Alkermes Plc   734,205.37 $ 1,505.121  Million 2,050 
Tvardi Therapeutics Inc   723,833.33 $ 8.686  Million 12 
Inmed Pharmaceuticals Inc  714,016.67 $ 4.284  Million 6 
Adaptimmune Therapeutics Plc  711,548.78 $ 175.041  Million 246 
Editas Medicine Inc   709,862.07 $ 61.758  Million 87 
Sanara Medtech Inc   706,040.12 $ 76.252  Million 108 
Theravance Biopharma inc   702,133.33 $ 63.192  Million 90 
Sensus Healthcare Inc   688,450.00 $ 41.307  Million 60 
Beam Therapeutics Inc   684,232.88 $ 349.643  Million 511 
Dyadic International Inc   672,909.60 $ 3.365  Million 5 
Biofrontera Inc   667,739.13 $ 61.432  Million 92 
Tg Therapeutics Inc   663,631.58 $ 264.789  Million 399 
Sunshine Biopharma Inc   659,189.84 $ 32.959  Million 50 
Dih Holding Us Inc   656,146.07 $ 116.794  Million 178 
Arvinas Inc   654,878.05 $ 161.100  Million 246 
Karyopharm Therapeutics Inc   651,061.40 $ 148.442  Million 228 
Organon and Co   640,900.00 $ 6,409.000  Million 10,000 
Cartesian Therapeutics Inc   639,173.33 $ 47.938  Million 75 
Maravai Lifesciences Holdings Inc   636,597.70 $ 276.920  Million 435 
Prophase Labs Inc   636,157.89 $ 12.087  Million 19 
Zoetis Inc   631,172.41 $ 9,152.000  Million 14,500 
Alphatec Holdings Inc   625,606.79 $ 571.179  Million 913 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.